Quantcast

Latest Valeant Pharmaceuticals Stories

2014-05-08 08:31:18

LAVAL, Quebec, May 8, 2014 /PRNewswire/ -- -- 2014 First Quarter Total Revenue $1.9 billion; an increase of 77% over the prior year -- Exceeded our expectations -- Launched 11 new products in the U.S. -- Positive organic growth in the U.S. despite the generic impact of Zovirax and RAM coupled with the new generic entry for Vanos -- Bausch + Lomb double-digit organic growth trend continued -- 2014 First Quarter GAAP EPS loss...

2014-05-01 16:33:44

LAVAL, Quebec, May 1, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders. The meeting and webcast will be held on Tuesday, May 20, 2014, at 9:00 a.m. ET at the International Headquarters, Laval Office: 2150 Saint Elzear Blvd. West, Laval Quebec, Canada H7L 4A8. Only shareholders of record at the close of business on the record date will be...

2014-04-28 16:31:44

Seasoned life sciences corporate development executive joins Endo to lead global acquisitions and integrations, to drive continued growth strategy DUBLIN, April 28, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today the appointment of Hemanth J. Varghese, Ph.D., CFA, as executive vice president of corporate development and strategy, effective immediately. Dr. Varghese brings to Endo a successful track record in corporate development and general...

2014-04-28 12:30:28

DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/b9jbpq/global) has announced the addition of the "Global Hypertension Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking...

2014-04-24 16:29:08

LAVAL, Quebec, April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square") today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer, J. Michael Pearson and Pershing Square Chief Executive Officer, William A. Ackman, outlining Valeant's proposed acquisition of...

2014-04-24 12:30:07

LAVAL, Quebec, April 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, May 8, 2014 at 8:00 a.m. ET (5:00 a.m. PT) to discuss results for the 2014 first quarter. The dial-in number to participate on this call is (877) 876-8393, confirmation code 28376511. International callers should dial (973) 200-3961, confirmation...

2014-04-23 08:31:50

LAVAL, Quebec, April 23, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today its nominees to stand for election to the Board of Directors at its annual meeting of shareholders on May 20, 2014. Given Valeant's increased size as a company and its ability to look at a broader set of business development opportunities, three of our Directors, who have full-time jobs looking at healthcare investment opportunities, feel that continued...

2014-04-22 08:32:39

This Offer Represents a Substantial Premium to Allergan's Unaffected Stock Price of $116.63 on April 10, 2014, the Day Before Pershing Square Crossed the 5% Schedule 13D Ownership Level and Commenced its Rapid Accumulation Program LAVAL, Quebec, April 22, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) announced today that it has submitted a merger proposal to the Board of Directors of Allergan, Inc. (NYSE: AGN) under which each Allergan...

2014-04-11 08:22:40

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, April 11, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Eli Lilly & Co. (NYSE: LLY), UnitedHealth Group, Inc. (NYSE: UNH), Valeant Pharmaceuticals International, Inc. (NYSE: VRX), Forest Laboratories Inc. (NYSE: FRX), and Zoetis Inc. (NYSE: ZTS). Private wealth members receive these notes ahead of publication. To reserve complementary membership,...

2014-04-10 08:28:43

DUBLIN, Apr. 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pnf52x/global ) has announced the addition of the "Global Dermatophytic Onychomycosis Therapeutics Market Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) The analysts forecast the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related